368,938 Shares in Revvity Inc. $RVTY Purchased by The Manufacturers Life Insurance Company

Key Points

• The Manufacturers Life Insurance Company acquired 368,938 Revvity shares worth approximately $41 million, giving it a 0.33% stake. Institutional investors collectively own 86.65% of the company.
• Analysts remain cautious, with a consensus “Hold” rating and an average price target of $108.36, below Revvity’s reported opening price of $126.31.
• Revvity exceeded quarterly expectations, reporting $1.41 in adjusted earnings per share versus $1.21 expected and revenue of $729.69 million. The company also declared a quarterly dividend of $0.07 per share, representing a 0.2% yield.

The Manufacturers Life Insurance Company acquired a new position in Revvity Inc. (NYSE:RVTY - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 368,938 shares of the company's stock, valued at approximately $41,048,000. The Manufacturers Life Insurance Company owned 0.33% of Revvity at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. EdgePoint Investment Group Inc. raised its position in shares of Revvity by 3.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock worth $771,044,000 after acquiring an additional 265,204 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Revvity by 5.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company's stock valued at $832,693,000 after purchasing an additional 434,570 shares in the last quarter. Janus Henderson Group PLC grew its stake in Revvity by 2.3% in the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company's stock worth $731,386,000 after purchasing an additional 186,956 shares during the period. BlackRock Inc. purchased a new stake in Revvity in the second quarter worth $852,070,000. Finally, Dimensional Fund Advisors LP raised its holdings in Revvity by 11.7% in the first quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company's stock worth $255,623,000 after purchasing an additional 305,837 shares in the last quarter. 86.65% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Wall Street Zen cut shares of Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 16th. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $96.00 to $90.00 and set a "neutral" rating for the company in a research note on Wednesday, May 6th. Sanford C. Bernstein began coverage on shares of Revvity in a research report on Friday, June 26th. They set a "market perform" rating and a $115.00 price target for the company. Stifel Nicolaus dropped their price objective on shares of Revvity from $110.00 to $100.00 and set a "hold" rating on the stock in a research note on Wednesday, May 6th. Finally, Robert W. Baird set a $117.00 price objective on shares of Revvity in a report on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, Revvity has an average rating of "Hold" and a consensus target price of $108.36.

Revvity Stock Performance

Shares of Revvity stock opened at $126.31 on Thursday. The stock has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 2.27 and a beta of 1.07. The firm's 50-day moving average is $112.94 and its 200 day moving average is $100.82. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $126.90. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.20. The business had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. Revvity's revenue was down 1.3% compared to the same quarter last year. During the same period last year, the business earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Sell-side analysts anticipate that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity's dividend payout ratio is presently 13.33%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source